Skip to main content

First Genetic Trust To Provide Genetic Bank to Pfizer

NEW YORK, Feb. 25 -  First Genetic Trust has signed a deal to provide Pfizer with a genetic bank for pharmacogenomics-based drug discovery, the company said today.

 

First Genetic Trust, of Chicago, will work with Pfizer to design an informatics-based solution, based on its entrust genetic banking system, that can track and manage access to samples and data in clinical trials that Pfizer is conducting.

 

The solution will allow users to integrate clinical data, genomic data, and informed consents, in an infrastctucture that complies with FDA regulations on electronic data submission, the company said.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.